CoChat

Tobacco and nicotine use

Le Foll, Bernard, Piper, Megan E., Fowler, Christie D., Tonstad, Serena, Bierut, Laura, Lu, Lin, Jha, Prabhat, Hall, Wayne D. · 2022 · Nature Reviews Disease Primers

The DOI matches its Crossref record; 198 of the 198 references it cites were found in a registry or an index.

Abstract

Tobacco smoking is a major determinant of preventable morbidity and mortality worldwide. More than a billion people smoke, and without major increases in cessation, at least half will die prematurely from tobacco-related complications. In addition, people who smoke have a significant reduction in their quality of life. Neurobiological findings have identified the mechanisms by which nicotine in tobacco affects the brain reward system and causes addiction. These brain changes contribute to the maintenance of nicotine or tobacco use despite knowledge of its negative consequences, a hallmark of addiction. Effective approaches to screen, prevent and treat tobacco use can be widely implemented to limit tobacco's effect on individuals and society. The effectiveness of psychosocial and pharmacological interventions in helping people quit smoking has been demonstrated. As the majority of people who smoke ultimately relapse, it is important to enhance the reach of available interventions and to continue to develop novel interventions. These efforts associated with innovative policy regulations (aimed at reducing nicotine content or eliminating tobacco products) have the potential to reduce the prevalence of tobacco and nicotine use and their enormous adverse impact on population health.

Overview

Integrity signals

Registry

Crossref · 10.1038/s41572-022-00346-w

Cites

198 of 198 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 198 references

Research works printed but not linked: 1

  1. Shanahan, W. R., Rose, J. E., Glicklich, A., Stubbe, S. & Sanchez-Kam, M. Lorcaserin for smoking cessation and associated weight gain: a randomized 12-week clinical trial. Nicotine Tob. Res. 19, 944–951 (2017).

Cited by

See all 317

Metadata

Authors
Le Foll, B., Piper, M. E., Fowler, C. D., Tonstad, S., Bierut, L., Lu, L., Jha, P., & Hall, W. D.
Affiliations
  • University of Wisconsin–Madison (US)
  • University of California, Irvine (US)
  • Oslo University Hospital (NO)
  • Washington University in St. Louis (US)
  • University of Toronto (CA)
  • The University of Queensland (AU)
Venue
Nature Reviews Disease Primers
Published
2022-03-24
Volume
8
Issue
1
Pages
19-19
ISSN
2056-676X (ISSN-L)
OpenAlex
W4220829235
Cited by
316
References
197
Citations by year
2026: 63 · 2025: 103 · 2024: 88 · 2023: 55 · 2022: 7
FWCI
8.71
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Nature Reviews Disease Primers (publishedVersion)
  • PubMed (publishedVersion)
Funders
University of Toronto
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Substance Exposure Effects
Keywords
smoking, nicotine, tobacco use disorder, nicotine dependence, brain reward system, smoking cessation, relapse, quality of life, tobacco-related morbidity and mortality, tobacco control, pharmacological interventions, psychosocial interventions, tobacco use screening
MeSH terms
Humans, Nicotine, Quality of Life, Smoking Cessation, Tobacco Use Cessation Devices, Tobacco Products, Tobacco Use

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Tobacco and nicotine use. https://app.cochat.ai/papers/10.1038/s41572-022-00346-w
The paper
Le Foll, B., Piper, M. E., Fowler, C. D., Tonstad, S., Bierut, L., Lu, L., Jha, P., & Hall, W. D. (2022). Tobacco and nicotine use. Nature Reviews Disease Primers. https://doi.org/10.1038/s41572-022-00346-w

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.